131 related articles for article (PubMed ID: 3570363)
1. C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance.
Füst G; Miszlay Z; Czink E; Varga L; Pálóczi K; Szegedi G; Hollán SR
Immunol Lett; 1987 Feb; 14(3):255-9. PubMed ID: 3570363
[TBL] [Abstract][Full Text] [Related]
2. Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia.
Miszlai Z; Czink E; Varga L; Pálóczi K; Szegedi G; Füst G; Hollán SR
Acta Med Hung; 1986; 43(4):389-95. PubMed ID: 3601584
[TBL] [Abstract][Full Text] [Related]
3. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
[TBL] [Abstract][Full Text] [Related]
4. Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia.
Varga L; Miszlay Z; Czink E; Pálóczi K; Szegedi G; Füst G; Hollán SR
Diagn Clin Immunol; 1987; 5(3):129-34. PubMed ID: 3319280
[TBL] [Abstract][Full Text] [Related]
5. Letter: Incomplete C4 consumption in leukaemia.
Spitzer R; Kalwinsky D; Stitzel A; Urmson J
Lancet; 1975 Nov; 2(7943):1041. PubMed ID: 53528
[No Abstract] [Full Text] [Related]
6. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
[TBL] [Abstract][Full Text] [Related]
7. Quantification of circulating immune complexes by chicken anti-C4 micro ELISA.
Larsson A; Sjöquist J
J Clin Lab Immunol; 1988 Sep; 27(1):39-43. PubMed ID: 3150766
[TBL] [Abstract][Full Text] [Related]
8. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
Schifferli JA; Steiger G; Schapira M
Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
[TBL] [Abstract][Full Text] [Related]
9. Incidence and clinical significance of circulating immune complexes in glomerulonephritis.
Valentijn RM; Daha MR; Van Es LA
Neth J Med; 1984; 27(9):340-9. PubMed ID: 6392910
[No Abstract] [Full Text] [Related]
10. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
11. Acquired C1-esterase inhibitor deficiency and recurrent herpes infection in a patient with chronic lymphocytic leukemia.
Minh D; Czink E; Füst G; Hollán SR
Diagn Immunol; 1983; 1(2):68-71. PubMed ID: 6680094
[TBL] [Abstract][Full Text] [Related]
12. C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.
Wautier JL; Tobelem GM; Peltier AP; Caen JP
Pathol Biol (Paris); 1975 Dec; 23 suppl():33-6. PubMed ID: 817252
[TBL] [Abstract][Full Text] [Related]
13. Relevance of circulating immune complexes in childhood acute lymphoblastic leukaemia.
Clague RB; Kumar S; Hann IM; Jones PH; Holt PJ
Int J Cancer; 1978 Sep; 22(3):227-30. PubMed ID: 279522
[TBL] [Abstract][Full Text] [Related]
14. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
15. Letter: Immune complexes in myasthenia gravis.
Casali P; Borzini P; Zanussi C
Lancet; 1976 Aug; 2(7981):378. PubMed ID: 60618
[No Abstract] [Full Text] [Related]
16. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
17. The presence of active C1 (C-1) on peripheral human lymphocytes.
Kitamura H; Teshima H; Day NK
Vox Sang; 1978; 35(4):197-206. PubMed ID: 99872
[TBL] [Abstract][Full Text] [Related]
18. Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).
Day NK; Winfield JB; Gee T; Winchester R; Teshima H; Kunkel HG
Clin Exp Immunol; 1976 Nov; 26(2):189-95. PubMed ID: 136325
[TBL] [Abstract][Full Text] [Related]
19. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
[TBL] [Abstract][Full Text] [Related]
20. Defective complement activity in chronic lymphocytic leukemia.
Heath ME; Cheson BD
Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
